All of the attention has got VCs excited, and companies on both sides of the Atlantic have convinced them to get out their chequebook: Danish startup Embla, which prescribes GLP-1 meds alongside ongoing clinical care and lifestyle advice for patients looking to lose weight in its home market and the UK, picked up a 10m Series A in August 2023 a year on from a 3.5m seed round
There are usually ways to address libido changes without discontinuing treatment, such as dose adjustments, nutritional changes, or adding hormone support
Some believe this could be the case with IGF-1, but others argue that supplementing with it comes with several harmful side effects
Services with visible escalation routes are expected to carry more trust than intake-only forms
The study shows that those who take L-Carnitine will have reduction of fats but increment of muscle mass
Should I avoid alcohol during dose increases